About Conference
The 10th International Conference on Neurological Disorders and Stroke is a premier international forum dedicated to advancing research, innovation, clinical practice, and professional collaboration in the fields of neurology, neuroscience, cerebrovascular medicine, and stroke care. Scheduled to be held on December 16–17, 2026, in Paris, France, this international gathering will bring together distinguished neurologists, neurosurgeons, stroke specialists, neuroscientists, researchers, rehabilitation professionals, healthcare practitioners, policymakers, educators, and students from across the globe.
Under the theme “Innovations in Neurology and Stroke Care: Advancing Prevention, Precision Diagnosis, Treatment and Brain Recovery,” the conference aims to promote scientific excellence, interdisciplinary collaboration, and innovative approaches to the prevention, diagnosis, treatment, and management of neurological disorders and stroke. The event will provide a dynamic platform for discussing emerging challenges, breakthrough research, advanced therapeutic strategies, and evidence-based approaches designed to improve neurological health and patient outcomes.
Participants will have the opportunity to engage in keynote presentations, plenary lectures, scientific sessions, oral and poster presentations, panel discussions, workshops, and interactive networking activities led by internationally recognized experts. The scientific program will explore a broad range of topics, including stroke prevention and management, acute ischemic and hemorrhagic stroke, neurointerventional procedures, neuroimaging, neurocritical care, neurodegenerative disorders, Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, neuroimmunology, neurogenetics, pediatric neurology, cognitive neurology, brain injury, and neurological rehabilitation.
The conference will also highlight emerging innovations transforming modern neurological care, including artificial intelligence in neurology, machine learning, precision medicine, digital health, advanced neuroimaging, biomarkers, brain-computer interfaces, neurotechnology, robotic rehabilitation, and data-driven approaches to neurological diagnosis and treatment. Special emphasis will be placed on multidisciplinary strategies for stroke recovery, cognitive rehabilitation, prevention of neurological disability, and improving long-term quality of life.
The conference offers an excellent opportunity for participants to establish international collaborations, develop research partnerships, exchange knowledge with global experts, and explore emerging trends in neurological and cerebrovascular medicine. Through meaningful scientific discussions, knowledge exchange, and professional networking, the 10th International Conference on Neurological Disorders and Stroke aims to inspire new research, strengthen global cooperation, encourage clinical innovation, and contribute to the advancement of better brain health, improved stroke outcomes, and the future of neurological care worldwide.
Sessions & Tracks
Contemporary approaches to neurological diagnosis and patient management, integrating clinical assessment, neurophysiology, advanced diagnostics, therapeutic decision-making, multidisciplinary care, and emerging clinical practices. Discussions will highlight complex neurological conditions, evolving treatment strategies, evidence-based approaches, and the translation of neurological discoveries into improved patient outcomes.
Innovative strategies for reducing stroke incidence through early risk identification, vascular health management, lifestyle modification, cardiovascular disease control, preventive medicine, patient education, and long-term monitoring. The program will also address secondary stroke prevention, recurrent stroke risk, healthy brain aging, and population-based approaches to improving cerebrovascular health.
Rapid diagnosis and treatment of acute ischemic stroke, with emphasis on advanced imaging, reperfusion strategies, thrombolytic therapies, mechanical thrombectomy, large-vessel occlusion management, streamlined stroke pathways, tele-stroke services, emergency response systems, and multidisciplinary coordination to improve treatment times and neurological outcomes.
Current approaches to intracerebral hemorrhage, subarachnoid hemorrhage, cerebral aneurysms, vascular malformations, cerebral venous disorders, and other cerebrovascular conditions, including early diagnosis, neurocritical management, surgical and endovascular interventions, prevention of secondary complications, and long-term neurological recovery.
Recent developments in minimally invasive cerebrovascular treatment, including advanced endovascular techniques, mechanical thrombectomy, aneurysm management, vascular device innovation, image-guided procedures, patient selection, procedural safety, treatment outcomes, and emerging technologies shaping the future of interventional neurology.
Advanced management of critically ill neurological patients requiring intensive monitoring and specialized intervention, covering severe stroke, brain edema, intracranial pressure, coma, status epilepticus, acute brain injury, neurological deterioration, cerebral protection, neuroprognostication, and coordinated neuro-intensive care.
Recent advances in Alzheimer's disease, Parkinson's disease, dementia, Huntington's disease, motor neuron disorders, and other neurodegenerative conditions, with emphasis on disease mechanisms, early detection, biomarkers, neuroimaging, therapeutic development, cognitive preservation, disease progression, supportive care, and strategies for promoting healthy brain aging.
Modern approaches to epilepsy and seizure disorders, including advanced diagnostic evaluation, EEG and neurophysiological monitoring, drug-resistant epilepsy, epilepsy surgery, seizure classification, emerging therapies, neurostimulation, pediatric epilepsy, personalized treatment, and strategies for improving long-term quality of life.
Emerging developments in multiple sclerosis and immune-mediated neurological disorders, focusing on disease mechanisms, neuroinflammatory pathways, biomarkers, advanced imaging, immunotherapies, disease-modifying treatments, autoimmune neurological conditions, personalized therapeutic strategies, and long-term disease monitoring.
Innovative approaches to neurological care across infancy, childhood, and adolescence, including pediatric stroke, epilepsy, cerebral palsy, developmental disorders, congenital neurological conditions, genetic diseases, neonatal neurological injury, developmental delay, early diagnosis, family-centred care, and multidisciplinary interventions supporting lifelong neurological health.
Advances in the prevention, diagnosis, acute management, surgical care, rehabilitation, and long-term recovery of traumatic brain and spinal injuries, with emphasis on neuroprotection, intracranial pressure management, concussion, cognitive impairment, spinal cord injury, neuroplasticity, functional restoration, and technologies supporting neurological recovery.
Innovative applications of MRI, CT, PET, functional imaging, vascular imaging, molecular imaging, imaging biomarkers, and computational analysis for improving neurological diagnosis and treatment planning. Integration of advanced imaging with artificial intelligence, clinical data, and precision medicine will support earlier detection and more individualized neurological care.
Applications of artificial intelligence, machine learning, predictive analytics, digital health, tele-neurology, wearable technologies, automated imaging analysis, clinical decision-support systems, brain-computer interfaces, and computational neuroscience in neurological research and clinical practice, alongside responsible innovation, data security, ethics, and patient-centred technology adoption.
Modern approaches to neurological rehabilitation following stroke, brain injury, and neurological disease, incorporating physical therapy, occupational therapy, speech and language rehabilitation, cognitive recovery, psychological support, neuroplasticity-based interventions, robotics, virtual reality, assistive technologies, digital rehabilitation, and personalized recovery programs.
Advances in genetic and molecular approaches to neurological disorders, including genomic medicine, inherited neurological diseases, molecular biomarkers, pharmacogenomics, proteomics, personalized treatment strategies, disease prediction, therapeutic response monitoring, and the translation of genetic and biomarker discoveries into clinically meaningful neurological care.
Current developments in the diagnosis and treatment of migraine, cluster headache, chronic headache, neuropathic pain, Parkinsonian disorders, tremor, dystonia, ataxia, and other movement-related neurological conditions, with attention to disease mechanisms, personalized therapies, neuromodulation, multidisciplinary management, and emerging treatment technologies.
Emerging developments in infections and conditions affecting the central and peripheral nervous systems, including meningitis, encephalitis, neuroviral diseases, neuroparasitic disorders, post-infectious neurological syndromes, neurological complications of emerging infections, diagnostic challenges, prevention strategies, and global approaches to neurological disease surveillance.
Advances in cognitive and behavioral aspects of neurological disease, including memory disorders, post-stroke cognitive impairment, neuropsychiatric complications, behavioral changes, depression, anxiety, dementia-related challenges, and psychological recovery. Integrated approaches addressing cognitive, emotional, social, and functional needs will support comprehensive neurological care.
Innovative strategies for neural repair and restoration, including stem cell research, gene therapy, cellular therapies, tissue engineering, neurostimulation, neural regeneration, neuroprotective strategies, novel drug delivery systems, and emerging therapeutic technologies aimed at restoring neurological function and improving outcomes in currently difficult-to-treat disorders.
Integration of basic neuroscience discoveries with clinical research and patient care through innovative clinical trials, therapeutic development, biomarkers, precision medicine, digital health, artificial intelligence, neurotechnology, regenerative medicine, and collaborative research. The focus will be on accelerating scientific discoveries toward practical applications that can transform the future of neurological and stroke care.
Market Analysis
The global market for neurological and stroke research, healthcare, diagnostics, therapeutics, rehabilitation, and related technologies represents a significant and expanding area of opportunity for scientific conferences. Neurological conditions affect more than 3 billion people worldwide, while WHO identifies neurological conditions as a leading cause of ill health and disability globally. Stroke remains one of the most significant neurological and cerebrovascular challenges, with approximately 11.9 million new strokes and 93.8 million people living with stroke globally in 2021.
The increasing burden of neurological disorders is creating strong demand for advances in prevention, early diagnosis, treatment, rehabilitation, and long-term patient management. The World Stroke Organization reports that the global burden of stroke has increased substantially over recent decades, with the estimated annual economic cost of stroke exceeding US$890 billion. The majority of stroke-related deaths and disability occur in low- and middle-income countries, creating significant opportunities for research collaboration, capacity building, healthcare innovation, and knowledge exchange.
A major growth area within the neurological healthcare landscape is the adoption of advanced technologies. Artificial intelligence, machine learning, digital health, tele-neurology, advanced neuroimaging, biomarkers, neurointerventional devices, brain-computer interfaces, robotics, and technology-assisted rehabilitation are increasingly influencing neurological research and clinical practice. Major scientific meetings are similarly expanding their programs around AI, brain health, stroke recovery, advanced diagnostics, and emerging interventions, demonstrating strong professional interest in these areas.
The conference therefore has a broad and multidisciplinary market, attracting neurologists, neurosurgeons, stroke specialists, neuroscientists, neurointerventionalists, radiologists, rehabilitation professionals, researchers, academicians, healthcare institutions, pharmaceutical companies, biotechnology companies, medical-device manufacturers, digital-health organizations, and technology innovators. Its focus on the theme “Innovations in Neurology and Stroke Care: Advancing Prevention, Precision Diagnosis, Treatment and Brain Recovery” provides an opportunity to connect established neurological science with rapidly developing areas such as precision medicine, AI, neurotechnology, regenerative medicine, and personalized rehabilitation.